Notable Labs, Ltd. Ordinary Shares
NTBL
NTBL was delisted on the 22nd of October, 2024.
28 hedge funds and large institutions have $295K invested in Notable Labs, Ltd. Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 10 reducing their positions, and 2 closing their positions.
100% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 2
8% more funds holding
Funds holding: 26 → 28 (+2)
43% less capital invested
Capital invested by funds: $518K → $295K (-$223K)
50% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 10
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $3K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$6.95K |
| 2 |
Belvedere Trading
Chicago,
Illinois
|
+$2.69K |
| 3 |
HSA
HBK Sorce Advisory
Erie,
Pennsylvania
|
+$2.57K |
| 4 |
ACA
Affinity Capital Advisors
Berkeley,
California
|
+$1.57K |
| 5 |
SG
StoneX Group
New York
|
+$1.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$41K |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
-$39.3K |
| 3 |
Jane Street
New York
|
-$13.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$10K |
| 5 |
Renaissance Technologies
New York
|
-$9.15K |
NTBL Hedge Fund Activity: Q4 2022 in Review
28 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Notable Labs, Ltd. Ordinary Shares (NTBL) for Q4 2022, worth a combined $295K — down 43% from $518K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new NTBL positions and 2 closed out — a net gain of 2 holders — while 5 added to existing stakes and 10 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $6.95K. The largest seller was Two Sigma Investments, cutting an estimated $41K.
- 28 institutional investors held Notable Labs, Ltd. Ordinary Shares (NTBL) as of Q4 2022, up from 26 in Q3 2022.
- Funds reported $295K of Notable Labs, Ltd. Ordinary Shares stock for Q4 2022, down 43% quarter-over-quarter.
- 4 funds opened new Notable Labs, Ltd. Ordinary Shares positions in Q4 2022 and 2 closed out, a net change of +2 holders.
- The largest Notable Labs, Ltd. Ordinary Shares buyer in Q4 2022 was Morgan Stanley, an estimated $6.95K added.
- The largest Notable Labs, Ltd. Ordinary Shares seller in Q4 2022 was Two Sigma Investments, an estimated $41K sold.
Based on aggregated 13F filings for Q4 2022.